Stocks to Watch Today: Physicswallah, Swiggy, Q-Line Biotech, Lupin, Wockhardt, Ashok Leyland, GMR Airports, PG Electroplast, West Coast Paper in focus on 29 May- Grow Mudra

Stocks to Watch Today: Physicswallah, Swiggy, Q-Line Biotech, Lupin, Wockhardt, Ashok Leyland, GMR Airports, PG Electroplast, West Coast Paper in focus on 29 May

29 May , 2026 By : Debdeep Gupta

Let's catch up on the latest news from the stock market. From significant investments to major deals, quarterly earnings, order wins, and new listings, here’s a quick look at which stocks will be in focus in today's trade:

Results Today

InterGlobe Aviation, Aegis Logistics, Bajaj Hindusthan Sugar, BEML, Glenmark Pharmaceuticals, Gujarat Gas, GVK Power & Infrastructure, Inox Wind, Ipca Laboratories, Lumax Auto Technologies, Natco Pharma, Olectra Greentech, Rubicon Research, and Steel Strips Wheels will announce their quarterly earnings today.

Results on May 30

Ahluwalia Contracts (India), Linde India, PTC Industries, Som Distilleries & Breweries, Suraj Estate Developers, Suraj Industries, Titagarh Rail Systems, TTK Healthcare, Uflex, and Veranda Learning Solutions will release their quarterly results on May 30.

Quarterly Earnings

Physicswallah Q4 (Consolidated YoY)

Loss narrows to Rs 74.9 crore Vs loss of Rs 293.1 crore

Revenue zooms 50.7% to Rs 918.8 crore Vs Rs 609.6 crore

Ashok Leyland Q4 (Consolidated YoY)

Profit grows 14.2% to Rs 1,290.7 crore Vs Rs 1,130.1 crore

Revenue soars 17.4% to Rs 17,246.4 crore Vs Rs 14,695.6 crore

Deepak Fertilisers & Petrochemicals Corporation Q4 (Consolidated YoY)

Profit sinks 49.7% to Rs 139.4 crore Vs Rs 277.2 crore

Revenue increases 12.9% to Rs 3,011.4 crore Vs Rs 2,667.4 crore

Bata India Q4 (Consolidated YoY)

Profit tumbles 95.2% to Rs 2.2 crore Vs Rs 45.9 crore

Revenue rises 5% to Rs 827.6 crore Vs Rs 788.2 crore

Expense towards VRS stand at Rs 28 crore Vs Nil

PC Jeweller Q4 (Consolidated YoY)

Profit surges 61.3% to Rs 152.9 crore Vs Rs 94.8 crore

Revenue grows 32.7% to Rs 927.3 crore Vs Rs 699 crore

GMR Airports Q4 (Consolidated YoY)

Profit stands at Rs 302.4 crore Vs loss of Rs 237.6 crore

Revenue jumps 37.5% to Rs 3,938.2 crore Vs Rs 2,863.3 crore

PG Electroplast Q4 (Consolidated YoY)

Profit plunges 55.3% to Rs 64.9 crore Vs Rs 145.2 crore

Revenue slips 10.1% to Rs 1,716.7 crore Vs Rs 1,909.9 crore

Gabriel India Q4 (Consolidated YoY)

Profit grows 3.5% to Rs 66.6 crore Vs Rs 64.4 crore

Revenue increases 12.7% to Rs 1,209.6 crore Vs Rs 1,073.2 crore

Hikal Q4 (Consolidated YoY)

Profit plunges 71.3% to Rs 14.4 crore Vs Rs 50.2 crore

Revenue declines 6% to Rs 519.4 crore Vs Rs 552.4 crore

Varroc Engineering Q4 (Consolidated YoY)

Profit zooms 236.9% to Rs 69.3 crore Vs Rs 20.6 crore

Revenue rises 12.8% to Rs 2,368.1 crore Vs Rs 2,099.2 crore

Exceptional item stands Nil Vs loss of Rs 56.4 crore

Enviro Infra Engineers Q4 (Consolidated YoY)

Profit falls 29.1% to Rs 51.9 crore Vs Rs 73.2 crore

Revenue rises 8.8% to Rs 427.3 crore Vs Rs 392.9 crore

Enviro Infra Engineers subsidiary Suyog Urja wins contract worth Rs 207.5 crore from CGE 30 Hybrid Energy for a hybrid renewable energy project

HG Infra Engineering Q4 (Consolidated YoY)

Profit falls 42.1% to 85.1 crore Vs Rs 147 crore

Revenue increases 4.8% to Rs 1,426.8 crore Vs Rs 1,360.9 crore

HG Infra Engineering declared as successful bidder by REC Power Development & Consultancy to establish inter-state transmission system worth Rs 114.5 crore per year in Jharkhand for 35 years

Stocks to Watch

Swiggy

The special resolution for the amendment of its Articles of Association received overall shareholder approval of 72.36 percent, falling short of the 75 percent threshold required for a special resolution by 2.64 percent.

The proposed amendments were a preparatory step towards the company’s objective of qualifying as an Indian Owned and Controlled Company (IOCC) under applicable Indian foreign exchange laws and regulations. Further, the IOCC classification will additionally require resident Indian shareholding to exceed 50 percent, along with applicable regulatory and shareholder approvals.

Tata Elxsi

The company announced the launch of AnaTel, an AI-native software development platform for healthcare and medical technology companies, co-developed with OpenAna, a provider of autonomous AI engineering platforms.

RITES

RITES signed a Memorandum of Understanding (MoU) with Crisil. The partnership aims to combine RITES’ extensive capabilities in transport infrastructure and engineering consultancy with Crisil’s strengths in data intelligence, analytics, research, and market insights to deliver integrated, data-driven infrastructure solutions.

Lupin

The company has received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (US FDA) for its Ankleshwar facility in Gujarat. It received the EIR following the closure of a product-specific Pre-Approval Inspection conducted from March 2 to March 7, 2026.

Wipro

The company announced an expanded partnership with ServiceNow to implement and scale the impact of agentic AI workflows across core enterprise functions such as IT, HR, procurement, and cybersecurity.

Indoco Remedies

The pharma company received EU GMP certification from the German Health Authority (Berlin) for its Oral Solid Dosage (OSD) manufacturing facility (Plant III) located in Baddi, Himachal Pradesh.

The inspection was conducted from April 22 to April 27, 2026.

Escorts Kubota

Escorts Kubota announced the introduction of Kubota Neostar, a significant upgrade to its compact tractor range in the 21–30 HP segment. Catering to the 21–27 HP range, this series is engineered for higher productivity, improved operator comfort, and smarter upgrade value. It is being introduced with a focus on high-potential sugarcane, vineyard, and horticulture clusters across Maharashtra, Karnataka, Madhya Pradesh, and Gujarat.

Wockhardt

The Central Drugs Standard Control Organisation (CDSCO) has granted authorization for the import and marketing of the antibiotic Zaynich (Zidebactam/Cefepime) in India. The approval is for the treatment of adult patients with complicated urinary tract infections (cUTI), including pyelonephritis, as well as cases involving concurrent Gram-negative bacteremia.

Zydus Lifesciences

The company's subsidiary, Zydus Therapeutics, has received Priority Review from the US Food and Drug Administration (US FDA) for the New Drug Application (NDA) for saroglitazar. The drug is used for the treatment of PBC in combination with ursodeoxycholic acid (UDCA) in adults who have had an inadequate response to UDCA, or as monotherapy in patients unable to tolerate UDCA.

The US FDA has assigned a Prescription Drug User Fee Act (PDUFA) target action date of November 27, 2026.

Reliance Industries

The 49th Annual General Meeting of the company’s members will be held on June 19.

Patanjali Foods

Due to alleged differences and anomalies in the turnover reported by the company and deduction of TDS, the Office of the Assistant Commissioner, North Division, Chennai, has issued a Show Cause Notice demanding Rs 1,352.9 crore, along with a penalty of Rs 135.29 crore, for the tax period 2022-23, and interest at 18 percent on CGST and SGST.

Coal India

The Government of India has decided to exercise the oversubscription option for the sale of 6.16 crore equity shares (representing a 1 percent stake) via the offer-for-sale route, in addition to the base offer size of 6.16 crore shares of Coal India. Accordingly, the total offer size will be up to 12.32 crore shares, representing a 2 percent stake.

Bulk Deals

Pine Labs

SBI Mutual Fund acquired an additional 1.3 crore equity shares (1.14 percent stake) in Pine Labs for Rs 177.79 crore, while Nippon India Mutual Fund bought 70 lakh shares (0.6 percent stake) for Rs 94.5 crore. Their buying price was Rs 135 per share.

SBI Mutual Fund, through SBI Midcap Fund, held a 5.24 percent stake in Pine Labs as of March 2026.

However, Altimeter Growth Partners Fund III LP, a venture capital fund owned by Altimeter Capital Management, sold 1.56 crore Pine Labs shares (1.35 percent stake) for Rs 211.08 crore at Rs 135.21 per share. The fund held a 1.39 percent stake in the fintech and commerce technology platform.

Indoco Remedies

ICICI Prudential Mutual Fund bought 13.58 lakh shares (1.47 percent stake) in pharma company Indoco Remedies for Rs 26.88 crore. The buying price was Rs 198 per share.

Prataap Snacks

Promoter Authum Investment & Infrastructure picked up an additional 1.3 lakh shares (0.54 percent stake) in Prataap Snacks for Rs 14.69 crore at Rs 1,123.15 per share. This is in addition to the 1.3 percent stake bought by Authum in the previous session.

As of March 2026, Authum, as a promoter, held a 43.66 percent stake in Prataap Snacks.

SME Listing

Q-Line Biotech

Bio Medica Laboratories

Autofurnish

Stocks Trade Ex-Dividend

Bajaj Auto

Bank of India

Advani Hotels & Resorts (India)

BCPL Railway Infrastructure

Caplin Point Laboratories

Eris Lifesciences